Trials / Completed
CompletedNCT01153282
Physical Functional Side Effects of Taxane Chemotherapy for Breast Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- Female
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Determine the characteristics of symptoms and functional impairment associated with chemotherapy induced peripheral neuropathy.
Detailed description
Taxanes, a type of chemotherapeutic agent prescribed to breast cancer patients, have a known physical side effect of chemotherapy induced peripheral neuropathy (CIPN). The purpose of this qualitative study is to understand the experience and physical functional side effects of taxanes. This is the first of a two phase study. The overall goal is to identify existing objective physical performance measures to assess functional side effects of taxanes.
Conditions
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2010-06-30
- Last updated
- 2020-03-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01153282. Inclusion in this directory is not an endorsement.